[Endoscopic third ventriculostomy for chronic communicating hydrocephalus in adults].

Background: Shunt devices to treat hydrocephalus are associated with a malfunction of 81 % at 12 years and 10 % of infection. The objective was to assess safeness and efficacy of endoscopic third ventriculostomy (ETV) for the treatment of chronic communicating hydrocephalus.

Methods: Eight patients with chronic communicating hydrocephalus were included in a period between September, 2012 and April, 2013.